Dianthus Therapeutics grants options for 26,000 shares to three new employees
DNTH•Dianthus Therapeutics granted non-qualified stock options covering 26,000 shares to three newly hired, non-executive employees on Nov. 2, 2026. The options have a 10-year term, an exercise price of $82.25 per share and vest over four years, with 25% vesting after one year.
1. Option grant details
Dianthus Therapeutics granted non-qualified stock options covering 26,000 shares to three newly hired, non-executive employees on Nov. 2, 2026. The options have a 10-year term and an exercise price of $82.25 per share. Vesting begins with 25% on the first anniversary of the vesting commencement date, followed by equal monthly installments over 36 months.
